Annual report pursuant to Section 13 and 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.20.4
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Schedule Of Cash Flow Supplemental [Line Items]        
Cash paid for interest   $ 102,859 $ 93,907 $ 98,411
Cash paid (refunds received) for income taxes, net   (116,916) 88,670 64,199
Cash balance classified as restricted [1]   13,847    
Noncash investing and financing activities:        
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [2]   (13,259) 22,013 (5,728)
Theatre properties acquired under finance leases     21,535 18,851
Investment in NCM – receipt of common units (see Note 8) $ 3,620 3,620 1,552 5,012
Dividends accrued on unvested restricted stock unit awards   (256) (670) (624)
Theatre properties acquired as distribution from equity investee (see Note 9)   102,719    
NCM        
Noncash investing and financing activities:        
Interest expense - NCM (see Notes 4 and 7)   $ (23,595) $ (28,624) $ (19,724)
[1] Funds are held as collateral for letters of credit associated with certain of the Company’s international subsidiary loans.  See further discussion at Note 13.
[2] Additions to theatre properties and equipment included in accounts payable as of December 31, 2019 and 2020 were $37,004 and $14,991, respectively.